After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Warhammer 40,000: Wrath & Glory lets players build their groups from different archetypes. They are brought together as ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Gilead Sciences (GILD) is a stock that can certainly grab the ...

Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...

The Handmaid’s Tale Season 6 will be the last, and I’m hopeful it will solve the Hulu show’s biggest plot hole: everything to do with Nick.

Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...

Forty years after the release of Atwood’s seminal novel, we are witnessing the echoes of real-life horror stories that inspired her to tell the tale.

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price upped by Wells Fargo & Company from $120.00 to $140.00 ...

Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...

Co-founder Finny Kuruvilla manages the firm’s largest two funds — Eventide Gilead and Eventide Healthcare and Life Sciences — and remains the firm’s largest owner, though more than 20 of ...

Hulu is nearing a series order for 'The Handmaid’s Tale' spinoff 'The Testaments' before the hit show's final season ...